Literature DB >> 8811648

Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos.

K H Schmidt1, E Günther, H S Courtney.   

Abstract

The human pathogenic microorganism Streptococcus pyogenes can resist against phagocytic attack of human granulocytes. Streptococcal M protein and hyaluronic acid were identified as virulence factors involved in this protection. So far, no experiments have been reported which describe the contribution of both components together in one system. We used the chicken embryo as an in vivo phagocytosis model to investigate the role of both components on the virulence of streptococci. For this, isogeneic mutants of group A streptococcal strains (GAS) which lack hyaluronic acid capsule (cap-) or M protein (M-) expression were used for infection and their virulence was compared with laboratory strains which had lost their ability to produce one or both virulence factors after long-time laboratory passages on blood agar. The experiments revealed that strains producing both M protein and hyaluronic capsule were highly virulent. Only 1-10 colony-forming units were enough to cause a 50% lethality of 12-day-old chicken embryos. Those strains lacking one of these components showed a significant decrease in virulence. Finally, strains which failed to express either hyaluronic acid or M protein showed an additional tenfold decrease in virulence. This indicates a partial contribution of both M protein and hyaluronic acid to the virulence of GAS in the chicken embryo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811648     DOI: 10.1007/bf02456131

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  28 in total

1.  Many group A streptococcal strains express two different immunoglobulin-binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M-type.

Authors:  L Stenberg; P O'Toole; G Lindahl
Journal:  Mol Microbiol       Date:  1992-05       Impact factor: 3.501

2.  Current knowledge of type-specific M antigens of group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

Review 3.  Streptococcal toxic shock syndrome.

Authors:  W Köhler
Journal:  Zentralbl Bakteriol       Date:  1990-03

4.  M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin.

Authors:  D S Retnoningrum; P P Cleary
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci.

Authors:  M R Wessels; J B Goldberg; A E Moses; T J DiCesare
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice.

Authors:  M R Wessels; M S Bronze
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

7.  Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro.

Authors:  J G HIRSCH; A B CHURCH
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

8.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

Authors:  C W Hoge; B Schwartz; D F Talkington; R F Breiman; E M MacNeill; S J Englender
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

Review 9.  Infection and molecular mimicry in autoimmune diseases of childhood.

Authors:  S Albani
Journal:  Clin Exp Rheumatol       Date:  1994 Sep-Oct       Impact factor: 4.473

10.  Common protective antigens of group A streptococcal M proteins masked by fibrinogen.

Authors:  E Whitnack; J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more
  12 in total

1.  Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.

Authors:  H M Schrager; J G Rheinwald; M R Wessels
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Conversion of M serotype 24 of Streptococcus pyogenes to M serotypes 5 and 18: effect on resistance to phagocytosis and adhesion to host cells.

Authors:  H S Courtney; S Liu; J B Dale; D L Hasty
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  Phosphorylation of the group A Streptococcal CovR response regulator causes dimerization and promoter-specific recruitment by RNA polymerase.

Authors:  Asiya A Gusa; Jinxin Gao; Virginia Stringer; Gordon Churchward; June R Scott
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

4.  Capsular Polysaccharide of Group A Streptococcus.

Authors:  Michael R Wessels
Journal:  Microbiol Spectr       Date:  2019-01

Review 5.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

6.  Mga is sufficient to activate transcription in vitro of sof-sfbX and other Mga-regulated virulence genes in the group A Streptococcus.

Authors:  Audry C Almengor; Matthew S Walters; Kevin S McIver
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

7.  Production of stabilized virulence factor-negative variants by group A streptococci during stationary phase.

Authors:  B A Leonard; M Woischnik; A Podbielski
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

8.  Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection.

Authors:  Ambrose Jong; Chun-Hua Wu; Han-Min Chen; Feng Luo; Kyung J Kwon-Chung; Yun C Chang; Craig W Lamunyon; Anna Plaas; Sheng-He Huang
Journal:  Eukaryot Cell       Date:  2007-06-01

9.  Thermoregulation of capsule production by Streptococcus pyogenes.

Authors:  Song Ok Kang; Jordan O Wright; Rafael A Tesorero; Hyunwoo Lee; Bernard Beall; Kyu Hong Cho
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

10.  covR Mediated Antibiofilm Activity of 3-Furancarboxaldehyde Increases the Virulence of Group A Streptococcus.

Authors:  Ganapathy Ashwinkumar Subramenium; Dharmaprakash Viszwapriya; Prasanth Mani Iyer; Krishnaswamy Balamurugan; Shunmugiah Karutha Pandian
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.